Abdelaziz MH, Ji X, Wan J, Abouelnazar FA, Abdelwahab SF, Xu H (2021) Mycobacterium-induced Th1, helminths-induced Th2 Cells and the potential vaccine candidates for allergic asthma: imitation of natural infection. Front Immunol 12:696734. https://doi.org/10.3389/fimmu.2021.696734
Article CAS PubMed PubMed Central Google Scholar
Abebe F, Bjune G (2009) The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol 157:235–243. https://doi.org/10.1111/j.1365-2249.2009.03967.x
Article CAS PubMed PubMed Central Google Scholar
Baranov MV, Kumar M, Sacanna S, Thutupalli S, van den Bogaart G (2021) Modulation of immune responses by particle size and shape. Front Immunol 11:607945. https://doi.org/10.3389/fimmu.2020.607945
Article CAS PubMed PubMed Central Google Scholar
Barral TD, Mariutti RB, Arni RK, Santos AJ, Loureiro D, Sokolonski AR, Azevedo V, Borsuk S, Meyer R, Portela RD (2019) A panel of recombinant proteins for the serodiagnosis of caseous lymphadenitis in goats and sheep. Microb Biotechnol 12:1313–1323. https://doi.org/10.1111/1751-7915.13454
Bastos BL, Loureiro D, Raynal JT, Guedes MT, Vale VL, Moura-Costa LF, Guimarães JE, Azevedo V, Portela RW, Meyer R (2013) Association between haptoglobin and IgM levels and the clinical progression of caseous lymphadenitis in sheep. BMC Vet Res 9:254. https://doi.org/10.1186/1746-6148-9-254
Article CAS PubMed PubMed Central Google Scholar
Bezerra FSB, Silva MTO, Rezende AFS, Lopes AS, Pinho RB, Seixas FK, Collares TV, Portela RWD, Azevedo V, Borsuk S (2021) Saponin-adjuvanted recombinant vaccines containing rCP00660, rCP09720 or rCP01850 proteins against Corynebacterium pseudotuberculosis infection in mice. Vaccine 18:2568–2574. https://doi.org/10.1016/j.vaccine.2021.03.062
Bretscher PA (2014) On the mechanism determining the TH1/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases. Scand J Immunol 79:361–376. https://doi.org/10.1111/sji.12175
Article CAS PubMed PubMed Central Google Scholar
Brown MA, Hural J (2017) Functions of IL-4 and control of its expression. Crit Rev Immunol 37:181–212. https://doi.org/10.1615/CritRevImmunol.v37.i2-6.30
Article CAS PubMed Google Scholar
Cheng J, Randall AZ, Sweredoski MJ, Baldi P (2005) SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res 33:W72-76. https://doi.org/10.1093/nar/gki396
Article CAS PubMed PubMed Central Google Scholar
Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47:45–148. https://doi.org/10.1002/9780470122921
Article CAS PubMed Google Scholar
Curtis MM, Way SS (2009) Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126:177–185. https://doi.org/10.1111/j.1365-2567.2008.03017.x
Article CAS PubMed PubMed Central Google Scholar
Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, Batalle JP, Diaz L, Trento A, Chang HY, Mitzner W, Ravetch J, Melero JA, Irusta PM, Polack FP (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15:34–41. https://doi.org/10.1038/nm.1894
Article CAS PubMed Google Scholar
Doligalska M, Joźwicka K, Laskowska M, Donskow-Łysoniewska K, Pączkowski C, Janiszowska W (2013) Changes in Heligmosomoides polygyrus glycoprotein pattern by saponins impact the BALB/c mice immune response. Exp Parasitol 135:524–531. https://doi.org/10.1016/j.exppara.2013.09.005
Article CAS PubMed Google Scholar
Dorella FA, Pacheco LG, Oliveira SC, Miyoshi A, Azevedo V (2006) Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res 37:201–218. https://doi.org/10.1051/vetres:2005056
Article CAS PubMed Google Scholar
Dorella FA, Pacheco LG, Seyffert N, Portela RW, Meyer R, Miyoshi A, Azevedo V (2009) Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development. Expert Rev Vaccines 8:205–213. https://doi.org/10.1586/14760584.8.2.205
Article CAS PubMed Google Scholar
Droppa-Almeida D, Vivas WL, Silva KK, Rezende AF, Simionatto S, Meyer R, Lima-Verde IB, Delagostin O, Borsuk S, Padilha FF (2016) Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain. Vaccine 34:1091–1096. https://doi.org/10.1016/j.vaccine.2015.12.064
Article CAS PubMed Google Scholar
Droppa-Almeida D, da Silva GA, Gaspar LMDAC, Pereyra BBS, Nascimento RJM, Borsuk S, Franceschi E, Padilha FF (2021) Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice. PLoS One 16:e0256864. https://doi.org/10.1371/journal.pone.0256864
Article CAS PubMed PubMed Central Google Scholar
Dummer LA, Araujo IL, Finger PF, Santos AG Jr, Rosa MC, Conceição FR, Fischer G, van Drunen Littel-van den Hurk, Leite FP (2014) Immune responses of mice against recombinant bovine herpesvirus 5 glycoprotein D. Vaccine 32:2413–2419. https://doi.org/10.1016/j.vaccine.2014.03.011
Article CAS PubMed Google Scholar
Egea E, Iglesias A, Salazar M, Morimoto C, Kruskall MS, Awdeh Z, Schlossman SF, Alper CA, Yunis EJ (1991) The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 173:531–538. https://doi.org/10.1084/jem.173.3.531
Article CAS PubMed Google Scholar
Emini EA, Hughes JV, Perlow DS, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55:836–839. https://doi.org/10.1128/JVI.55.3.836-839.1985
Article CAS PubMed PubMed Central Google Scholar
Ferluga J, Yasmin H, Al-Ahdal MN, Bhakta S, Kishore U (2020) Natural and trained innate immunity against Mycobacterium tuberculosis. Immunobiology 225:151951. https://doi.org/10.1016/j.imbio.2020.151951
Article CAS PubMed Google Scholar
Fernandes AP, Costa MM, Coelho EA, Michalick MS, de Freitas E, Melo MN, Luiz Tafuri W, Resende Dde M, Hermont V, Abrantes Cde F, Gazzinelli RT (2008) Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 26:5888–5895. https://doi.org/10.1016/j.vaccine.2008.05.095
Article CAS PubMed Google Scholar
Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: Walker JM (ed) The proteomics protocols handbook: springer protocols handbooks. Humana Press, Nova Jersey, pp 571–607
Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, Kolbe L, Kölsch E, Podlaski FJ, Gately MK, Rüde E (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol 25:823–829. https://doi.org/10.1002/eji.1830250329
Article CAS PubMed Google Scholar
Ghanavi J, Farnia P, Farnia P, Velayati AA (2021) The role of interferon-gamma and interferon-gamma receptor in tuberculosis and nontuberculous mycobacterial infections. Int J Mycobacteriol 10:349–357. https://doi.org/10.4103/ijmy.ijmy_186_21
Article CAS PubMed Google Scholar
Gong Z, Martin-Garcia JM, Daskalova SM, Craciunescu FM, Song L, Dörner K, Hansen DT, Yang JH, LaBaer J, Hogue BG, Mor TS, Fromme P (2015) Biophysical characterization of a vaccine candidate against hiv-1: the transmembrane and membrane proximal domains of HIV-1 gp41 as a maltose binding protein fusion. PLoS ONE 10:e0136507. https://doi.org/10.1371/journal.pone.0136507
Article CAS PubMed PubMed Central Google Scholar
Guler R, Ozturk M, Sabeel S, Motaung B, Parihar SP, Thienemann F, Brombacher F (2021) Targeting molecular inflammatory pathways in granuloma as host-directed therapies for tuberculosis. Front Immunol 12:733853. https://doi.org/10.3389/fimmu.2021.733853
Article CAS PubMed PubMed Central Google Scholar
Hodgson AL, Carter K, Tachedjian M, Krywult J, Corner LA, McColl M, Cameron A (1999) Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. Vaccine 17:802–808. https://doi.org/10.1016/s0264-410x(98)00264-3
Article CAS PubMed Google Scholar
Hu W, Spaink HP (2022) The role of TLR2 in infectious diseases caused by mycobacteria: from cell biology to therapeutic target. Biology 11:246. https://doi.org/10.3390/biology11020246
Article CAS PubMed PubMed Central Google Scholar
Huynh KK, Joshi SA, Brown EJ (2011) A delicate dance: host response to mycobacteria. Curr Opin Immunol 23:464–472. https://doi.org/10.1016/j.coi.2011.06.002
Article CAS PubMed Google Scholar
Khademi F, Yousefi A, Derakhshan M, Najafi A, Tafaghodi M (2019) Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration. Iran J Basic Med Sci 22:893–900. https://doi.org/10.22038/ijbms.2019.33962.8079
Article PubMed PubMed Central Google Scholar
Körner H, McMorran B, Schlüter D, Fromm P (2010) The role of TNF in parasitic diseases: still more questions than answers. Int J Parasitol 40:879–888. https://doi.org/10.1016/j.ijpara.2010.03.011
Article CAS PubMed Google Scholar
Kumar S, Sunagar R, Gosselin E (2019) Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants. Front Immunol 10:1144. https://doi.org/10.3389/fimmu.2019.01144
留言 (0)